Evaluation of the Febrile Infant

Evaluation of the Febrile Infant
Emily M. Herzberg
Lauren Allister
Background
The evaluation and management of the febrile infant <3 months of age has been debated for decades. The prevalence of serious bacterial infection (SBI) in infants 0 to 3 months with fever is approximately 8%, with the highest prevalence (25%) in infants <2 weeks.1 Determining which febrile infants have an underlying SBI cannot be ascertained solely based on clinical appearance, often necessitating invasive diagnostic testing. Prior to these studies, common practice had been to hospitalize infants <3 months of age for evaluation, antibiotic administration, and observation, which was costly, time consuming, and resource heavy. These landmark investigations were the first to suggest possible pathways for risk stratification of young febrile infants.
Landmark Studies in the Evaluation of the Febrile Infant Rochester Group Objectives
To determine whether results of physical examination, WBC/band count, and UA could predict and stratify risk for SBI.
Methods
Single center, prospective, cohort study in an ED from 1982 to 1984.
Patients
233 previously healthy infants age <89 d hospitalized for sepsis evaluation, stratified to low- and high-risk groups. Infants classified as low risk:
  • No obvious source of infection
  • Peripheral WBC count 5,000–15,000/mm3
  • <1,500 bands/mm3
  • UA <10 WBCs/hpf
  • No recent antibiotic therapy
CXR and CSF results were not used for risk stratification.
Intervention
Performance of CBC/differential, UA, LP; blood, urine, and CSF cultures. Viral/stool swabs and CXR obtained dependent on season and symptoms. All were hospitalized and 200 received parenteral antibiotics.
Outcomes
Incidence of SBI among low-risk compared to high-risk infants, and clinical and laboratory findings predictive of SBI.
Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Evaluation of the Febrile Infant

Full access? Get Clinical Tree

Get Clinical Tree app for offline access